Wendell David Associates Inc Abbott Laboratories Transaction History

Wendell David Associates Inc

  • $1.05 Billion
  • Q3 2024

A detailed history of Wendell David Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Wendell David Associates Inc holds 223,540 shares of ABT stock, worth $26.3 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
223,540
Previous 224,375 0.37%
Holding current value
$26.3 Million
Previous $23.3 Million 9.31%
% of portfolio
2.44%
Previous 2.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$100.07 - $118.13 $83,558 - $98,638
-835 Reduced 0.37%
223,540 $25.5 Million
Q2 2024

Jul 22, 2024
SELL
$100.73 - $112.44 $161,570 - $180,353
-1,604 Reduced 0.71%
224,375 $23.3 Million
Q1 2024

Apr 22, 2024
BUY
$109.52 - $120.96 $90,354 - $99,792
825 Added 0.37%
225,979 $25.7 Million
Q4 2023

Jan 22, 2024
BUY
$90.19 - $110.4 $68,093 - $83,352
755 Added 0.34%
225,154 $24.8 Million
Q3 2023

Oct 20, 2023
BUY
$95.53 - $114.62 $279,234 - $335,034
2,923 Added 1.32%
224,399 $21.7 Million
Q2 2023

Jul 20, 2023
SELL
$100.78 - $112.29 $65,003 - $72,427
-645 Reduced 0.29%
221,476 $24.1 Million
Q1 2023

Apr 19, 2023
BUY
$96.86 - $114.01 $54,822 - $64,529
566 Added 0.26%
222,121 $22.5 Million
Q4 2022

Jan 17, 2023
SELL
$95.06 - $111.52 $12,738 - $14,943
-134 Reduced 0.06%
221,555 $24.3 Million
Q3 2022

Oct 18, 2022
SELL
$96.76 - $112.03 $33,382 - $38,650
-345 Reduced 0.16%
221,689 $21.5 Million
Q2 2022

Jul 14, 2022
BUY
$102.07 - $123.37 $807,986 - $976,596
7,916 Added 3.7%
222,034 $24.1 Million
Q1 2022

Apr 22, 2022
SELL
$114.02 - $139.04 $484,585 - $590,920
-4,250 Reduced 1.95%
214,118 $25.3 Million
Q4 2021

Jan 24, 2022
SELL
$115.53 - $141.46 $154,348 - $188,990
-1,336 Reduced 0.61%
218,368 $30.7 Million
Q3 2021

Oct 19, 2021
SELL
$116.66 - $129.06 $5,833 - $6,453
-50 Reduced 0.02%
219,704 $26 Million
Q2 2021

Jul 19, 2021
BUY
$105.79 - $124.53 $686,153 - $807,701
6,486 Added 3.04%
219,754 $25.5 Million
Q1 2021

Apr 20, 2021
BUY
$108.84 - $128.23 $649,774 - $765,533
5,970 Added 2.88%
213,268 $25.6 Million
Q4 2020

Jan 22, 2021
SELL
$105.0 - $114.42 $69,825 - $76,089
-665 Reduced 0.32%
207,298 $22.7 Million
Q3 2020

Oct 20, 2020
BUY
$91.64 - $111.29 $530,137 - $643,812
5,785 Added 2.86%
207,963 $22.6 Million
Q2 2020

Jul 17, 2020
BUY
$76.57 - $98.0 $959,422 - $1.23 Million
12,530 Added 6.61%
202,178 $18.5 Million
Q1 2020

Apr 16, 2020
BUY
$62.82 - $91.86 $14,762 - $21,587
235 Added 0.12%
189,648 $15 Million
Q4 2019

Jan 17, 2020
SELL
$78.51 - $87.4 $80,472 - $89,585
-1,025 Reduced 0.54%
189,413 $16.5 Million
Q3 2019

Oct 22, 2019
SELL
$81.84 - $88.74 $128,488 - $139,321
-1,570 Reduced 0.82%
190,438 $15.9 Million
Q2 2019

Jul 16, 2019
SELL
$72.88 - $85.0 $185,115 - $215,900
-2,540 Reduced 1.31%
192,008 $16.1 Million
Q1 2019

Apr 11, 2019
SELL
$66.22 - $80.06 $92,906 - $112,324
-1,403 Reduced 0.72%
194,548 $15.6 Million
Q4 2018

Jan 17, 2019
SELL
$65.56 - $74.27 $170,390 - $193,027
-2,599 Reduced 1.31%
195,951 $14.2 Million
Q3 2018

Oct 12, 2018
SELL
$60.81 - $73.36 $123,140 - $148,554
-2,025 Reduced 1.01%
198,550 $14.6 Million
Q2 2018

Jul 16, 2018
BUY
$57.57 - $63.54 $141,104 - $155,736
2,451 Added 1.24%
200,575 $12.2 Million
Q1 2018

Apr 11, 2018
SELL
$56.27 - $63.62 $260,698 - $294,751
-4,633 Reduced 2.29%
198,124 $11.9 Million
Q4 2017

Jan 16, 2018
SELL
$53.68 - $57.47 $509,691 - $545,677
-9,495 Reduced 4.47%
202,757 $11.6 Million
Q3 2017

Oct 17, 2017
BUY
$48.06 - $53.64 $10.2 Million - $11.4 Million
212,252
212,252 $11.3 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email